NO975661D0 - Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer - Google Patents

Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer

Info

Publication number
NO975661D0
NO975661D0 NO975661A NO975661A NO975661D0 NO 975661 D0 NO975661 D0 NO 975661D0 NO 975661 A NO975661 A NO 975661A NO 975661 A NO975661 A NO 975661A NO 975661 D0 NO975661 D0 NO 975661D0
Authority
NO
Norway
Prior art keywords
triazoles
cancer
bis
drug
preparation
Prior art date
Application number
NO975661A
Other languages
English (en)
Other versions
NO975661L (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO975661D0 publication Critical patent/NO975661D0/no
Publication of NO975661L publication Critical patent/NO975661L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO975661A 1995-06-07 1997-12-05 Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer NO975661L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/473,818 US5665751A (en) 1995-06-07 1995-06-07 Pharmaceutical composition for inhibiting the growth of cancers
PCT/US1996/007446 WO1996040120A1 (en) 1995-06-07 1996-05-22 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers

Publications (2)

Publication Number Publication Date
NO975661D0 true NO975661D0 (no) 1997-12-05
NO975661L NO975661L (no) 1998-02-09

Family

ID=23881116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975661A NO975661L (no) 1995-06-07 1997-12-05 Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer

Country Status (20)

Country Link
US (3) US5665751A (no)
EP (1) EP0831815A1 (no)
JP (1) JPH11506733A (no)
KR (1) KR19990022618A (no)
CN (1) CN1259867A (no)
AR (1) AR003430A1 (no)
AU (1) AU717201B2 (no)
BR (1) BR9609093A (no)
CA (1) CA2223803A1 (no)
CZ (1) CZ391897A3 (no)
HU (1) HUP9802629A3 (no)
IL (1) IL118426A (no)
NO (1) NO975661L (no)
NZ (1) NZ308393A (no)
PL (1) PL324078A1 (no)
SK (1) SK168797A3 (no)
TR (2) TR199701535T1 (no)
TW (1) TW466113B (no)
WO (1) WO1996040120A1 (no)
ZA (1) ZA964377B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286758B6 (en) * 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
NZ503921A (en) * 1995-08-04 2002-03-01 Procter & Gamble Use of fluconazole mixed with chemotherapeutic agents for inhibiting the growth of cancers or tumors
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
CN100334084C (zh) * 2005-04-26 2007-08-29 武汉大学 联三唑化合物及其制备方法和用途
CN100451007C (zh) * 2006-10-12 2009-01-14 杭州宇龙化工有限公司 含芳醚双三氮唑类化合物及其用途
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
US8536113B2 (en) 2006-12-21 2013-09-17 Janssen Biotech, Inc. EGFR binding peptides and uses thereof
US8278415B2 (en) 2006-12-21 2012-10-02 Centocor, Inc. Dimeric high affinity EGFR constructs and uses thereof
KR100980328B1 (ko) * 2007-12-14 2010-09-06 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는트리아졸릴-티오-에타논 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 암 예방 및 치료용조성물
CN102321036A (zh) * 2011-07-13 2012-01-18 王健祥 一种氟康唑可溶性盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) * 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) * 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration

Also Published As

Publication number Publication date
TR200102287T2 (tr) 2002-06-21
AR003430A1 (es) 1998-08-05
JPH11506733A (ja) 1999-06-15
PL324078A1 (en) 1998-05-11
USRE37003E (en) 2000-12-26
NO975661L (no) 1998-02-09
CA2223803A1 (en) 1996-12-19
KR19990022618A (ko) 1999-03-25
NZ308393A (en) 2001-04-27
AU717201B2 (en) 2000-03-23
IL118426A0 (en) 1996-09-12
CZ391897A3 (cs) 1998-05-13
AU5802196A (en) 1996-12-30
BR9609093A (pt) 1999-06-29
SK168797A3 (en) 1998-12-02
TW466113B (en) 2001-12-01
CN1259867A (zh) 2000-07-12
HUP9802629A2 (hu) 1999-04-28
IL118426A (en) 2001-03-19
HUP9802629A3 (en) 2000-01-28
US5840742A (en) 1998-11-24
ZA964377B (en) 1997-02-17
TR199701535T1 (xx) 1998-03-21
US5665751A (en) 1997-09-09
EP0831815A1 (en) 1998-04-01
WO1996040120A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
NO975661D0 (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
NO975662D0 (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
DE69626168D1 (de) Infusionskatheter
ATE187063T1 (de) Arzneimittel
DE69632852D1 (de) Teleskopischer katheter
DE69631514D1 (de) Steuerbarer katheter
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
BR9602637A (pt) Cateter
ATE193298T1 (de) Therapeutische verbindungen
DE69326539D1 (de) Zytotoxische arzneimittel therapie
AU4048295A (en) Peptide medicaments for the treatment of disease
NO910395D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
NO911429D0 (no) Stoffbehandling.
NO178150C (no) Ett-trinnsfremgangsmåte for fremstilling av diritromycin
GB9508823D0 (en) Drug Derivatives
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
EP0790062A4 (en) REMEDY FOR HEART DISEASE
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
DE59602953D1 (de) Fungizide wirkstoffkombinationen
NO911430L (no) Stoffbehandlingsmetode.
DE59602890D1 (de) Fungizide wirkstoffkombinationen
NO913162D0 (no) Farmasoeytisk preparat for behandling av tonsillitt.
MX9207407A (es) Mejora de la biodisponibilidad de agentes terapeuticos proteoliticamente labiles.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application